PRMT5-FOXM1 axis activates β-catenin/IL8 signaling to drive angiogenesis of gastric cancer
- 6 June 2025
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 134, 111925
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82002563)
- Henan Provincial Science and Technology Research Project (LHGJ20190005)
This publication has 28 references indexed in Scilit:
- Gastric cancerThe Lancet, 2020
- Protein arginine methyltransferase 5-mediated epigenetic silencing of IRX1 contributes to tumorigenicity and metastasis of gastric cancerBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2018
- PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinomaCancer Medicine, 2018
- PRMT5 Is a Critical Regulator of Breast Cancer Stem Cell Function via Histone Methylation and FOXP1 ExpressionCell Reports, 2017
- The dual epigenetic role of PRMT5 in acute myeloid leukemia: gene activation and repression via histone arginine methylationLeukemia, 2015
- The PRMT5 arginine methyltransferase: many roles in development, cancer and beyondCellular and Molecular Life Sciences, 2015
- Angiogenesis in gastric cancer: hitting the target?The Lancet, 2014
- Transcriptional Regulation and Its Misregulation in DiseaseCell, 2013
- FoxM1 Promotes β-Catenin Nuclear Localization and Controls Wnt Target-Gene Expression and Glioma TumorigenesisCancer Cell, 2011
- The protein arginine methyltransferase family: an update about function, new perspectives and the physiological role in humansCellular and Molecular Life Sciences, 2009